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ABSTRACT
Cyclin D1 is an important molecular driver of human breast cancer but better 
understanding of its oncogenic mechanisms is needed, especially to enhance efforts 
in targeted therapeutics. Currently, pharmaceutical initiatives to inhibit cyclin D1 
are focused on the catalytic component since the transforming capacity is thought 
to reside in the cyclin D1/CDK activity. We initiated the following study to directly 
test the oncogenic potential of catalytically inactive cyclin D1 in an in vivo mouse 
model that is relevant to breast cancer. Herein, transduction of cyclin D1–/– mouse 
embryonic fibroblasts (MEFs) with the kinase dead KE mutant of cyclin D1 led to 
aneuploidy, abnormalities in mitotic spindle formation, autosome amplification, 
and chromosomal instability (CIN) by gene expression profiling. Acute transgenic 
expression of either cyclin D1WT or cyclin D1KE in the mammary gland was sufficient 
to induce a high CIN score within 7 days. Sustained expression of cyclin D1KE induced 
mammary adenocarcinoma with similar kinetics to that of the wild-type cyclin D1. 
ChIP-Seq studies demonstrated recruitment of cyclin D1WT and cyclin D1KE to the 
genes governing CIN. We conclude that the CDK-activating function of cyclin D1 is 
not necessary to induce either chromosomal instability or mammary tumorigenesis.
 INTRODUCTION
Activation of the cyclin D1 oncogene, often by 
amplifi­cation­ or­ rearrangement,­ is­ a­ major­ driver­ of­
multiple­ types­ of­ human­ tumors­ including­ breast­ and­
squamous­ cell­ cancers,­ B-cell­ lymphoma,­ myeloma,­




the­ regulatory­ subunit­ of­ the­ cyclin-dependent­ kinase­
(CDK4/6)­ holoenzyme.­ Tumors­ overexpressing­ cyclin­
D1­ tend­ to­ display­ normal­ levels­ of­ proliferation­ and­
expression­of­E2F­target­genes,­which­contrasts­with­tumors­
overexpressing­cyclin­E­or­an­activator­for­pRb­[4,­5].­Breast­






























immunoprecipitation­ studies­ identified­ cyclin­ D1­ in­ the­
context­ of­ local­ chromatin,­ and­ the­ abundance­ of­ cyclin­
D1­determined­the­recruitment­of­transcription­factors­(TF)­
[19].­The­recruitment­of­cyclin­D1­to­cis­elements­enriches­
for­ histone­ acetylases­ (p300/CBP),­ histone­ deacetylases,­
the­ methylase­ SUV39­ and­ the­ heterochromatin­ protein­








chromosomes­ and/or­ structural­ chromosomal­ aberrations­
[24].­ However,­ the­ contribution­ of­ CIN­ to­ the­ molecular­
mechanisms­ governing­ relatively­ early­ changes­ in­ tumor­
progression­remains­to­be­fully­understood­[25,­26],­especially­








Cyclin D1 induction of mitotic abnormalities is 
kinase-independent
Recent­ studies­ using­ SKY­ analysis­ and­ gene­
expression­profiling­have­demonstrated­that­re-expression­
of cyclin D1WT­ in­ cyclin­ D1-deficient­ cells­ results­ in­
CIN­[22].­In­order­to­test­the­kinase-independent­function­
of­cyclin­D1­in­aneuploidy­and­tumorigenesis,­we­utilized­











or­ p27Kip1­ [16].­ Collectively­ these­ studies­ demonstrate­
that­ the­kinase­ function­of­ cyclin­D1KE­ is­ abrogated­or­
substantially­blunted.
Prior­ to­ engaging­ in­ studies­ to­ question­whether­
the­ induction­ of­ aneuploidy­ by­ cyclin­ D1­ is­ kinase-
independent­ we­ verified­ the­ relative­ abundance­ and­
nuclear­localization­of­cyclin­D1KE.­In­cyclin D1–/–­cells­
rescued­ with­ either­ cyclin D1WT­ or­ cyclin D1KE, the 
protein­ abundance­ was­ similar­ between­ the­ two­ cell­
lines­ (Supplementary­ Figure­ S1B).­ In­ addition­ there­
was­ no­difference­ in­ the­ abundance­within­ the­ nuclear­
compartment­(Supplementary­Figures­S1C­and­S1D).­Next­
we,­determined­the­subcellular­compartmentalization­of­ 














and­31%­in­the­cyclin D1–/–KE Rescue­cells­compared­to­control 
(p­ =­ 0.0051­ and­p­ =­ 0.0004­ respectively)­ (Figures­ 1A­
and­ 1B).­ The­ generation­ of­ multi-polar­ spindle­ cells­






compared­ to­ control­ cells­ (Figures­ 1A­ and­ 1C). 
The­ alteration­ of­ spindle­ architecture­ associated­ with­
metaphase­ plate­ disruption­was­measured­by­ assessing­
metaphase­plate­length­and­width­(ChL,­Chw)­and­spindle­
length­ and­ width­ (SpL,­ SpW)­ (Figures­ 1D­ and­ 1E). 
Consistent­ with­ the­ increase­ in­ spindle/centrosome­
abnormalities,­ the­ ChW­ and­ SpL­ were­ significantly­
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increased­in­cyclin D1-/-D1 Rescue­and­cyclin D1-/-KE Rescue­cells­
compared­with­cyclin D1-/-Control­cells.
Cyclin D1KE induces aneuploidy
Spectral­karyotyping­(SKY)­was­conducted­comparing­
cyclin D1-/-KE Rescue­ vs.­ cyclin D1-/-Control­ cells.­Aneuploidy­
refers­to­the­loss­or­gain­of­whole­or­partial­chromosomes­





of­ all­ metaphases­ (Figures­ 2A–2C­ and­ Supplementary­
Figure­S3A–S3C).­At­72­hours­cyclin D1-/-KE Rescue­induced­
aneuploidy­ in­ 42%­ of­ cells,­ compared­ to­ 7%­ in­ cyclin 
D1-/-Control­cells.­At­120­hours,­100%­of­cyclin D1-/-KE Rescue 
cells­demonstrated­aneuploidy­compared­to­70%­in­cyclin 
D1-/-Control­MEFs­(Figure­2D,­and­2F).­Therefore,­induction­
of­ aneuploidy­ by­ cyclin­D1­ is­ kinase-independent.­ SKY­
analysis­ assigns­ chromosomal­ rearrangements­ classified­
as­ deletions,­ duplications­ and­ translocations.­ There­ was­
no­significant­difference­ in­chromosomal­rearrangements­
between­cyclin D1-/-Control­and­cyclin D1-/-KE Rescue­MEFs.
To­further­assess­the­role­of­cyclin­D1­kinase­activity­
in­ aneuploidy­ induction­we­ transduced­MEFs­with­ cyclin­
Figure 1: Cyclin D1 induction of centrosome amplification and mitotic spindle disorganization is independent of 
cyclin D1 kinase activity. (A)­Representative­confocal­maximum­Z­projections­of­mitotic­cells­from­cyclin D1-/-Control, cyclin D1-/-D1 
Rescue­and­cyclin D1-/-KE Rescue.­Cells­were­immunostained­for­α-tubulin­(red),­γ-tubulin­(yellow),­crest­(green),­and­Hoechst­(blue).­Scalebar­
5­ μm.­ (B)­ Frequencies­ of­mitotic­ cells­with­multiple­ polar­ spindles­ (**p­ =­ 0.0051,­ ***p­ =­ 0.0004;­ calculated­ by­Fisher­ contingency­
test).­(C)­Frequency­of­cells­with­multiple­chromosomes­(*p­=­0.021,­***p­=­0.0007;­calculated­by­Fisher­contingency­test).­(D and E) 





PD0332991,­ and­ assessed­ the­ induction­ of­ aneuploidy.­
Karyotyping­was­ conducted­ comparing­ cyclin D1-/-KE Rescue 
vs­ cyclin D1-/-Control­ cells.­Western­ blot­ analysis­ confirmed­
CDK4/6­antagonist­PD0332991­diminished­phosphorylation­
of­pRB­at­S780­ in­cyclin D1-/-Control­ and­cyclin D1-/-KE Rescue 
MEFs;­cyclin D1-/-D1 Rescue­3T3­cells­were­used­as­a­positive­
control­ for­ induction­ of­ phosphorylation­ of­ pRB­ at­ S780­
(Supplementary­ Figure­ S4A).­ Representative­ metaphase­
spreads­ and­ numerical­ quantitation­ are­ shown­ from­












Figure 2: Cyclin D1 kinase-independent induction of aneuploidy. Representative­metaphases­from­spectral­karyotyping­(SKY)­
on­MEFs­of­cyclin D1-/-Control­at­72­hours­(P6)­(A), cyclin D1-/-KE Rescue­at­72­hours­(P6)­(B)­and­cyclin D1-/-KE Rescue­at­120­hours­(C).­Each­panel­
contains­the­following­images:­inverted­4’,6-diamidino-2-phenylindole­(DAPI)­image­of­the­metaphase­(top­left­corner),­raw­spectral­image­
of­the­metaphase­(top­right)­and­classified­metaphase­of­the­same­metaphase­(lower­panel).­(D)­Scatter­plots­of­chromosomal­number­across­
metaphase­spreads­from­cyclin D1-/-Control­and­cyclin D1-/-KE Rescue­cells­showing­the­total­number­of­chromosomes­at­72­hours­and­120­hours­
from­cells­with­the­noted­genotype.­The­grey­shaded­bar­represents­expected­deviation­from­normal­at­2N­and­4N­(+/–­2­chromosomes).­
Applying­the­chi-square­test­of­association­by­comparing­cyclin D1-/-­versus­the­cyclin D1-/-D1 Rescue­MEFs,­and­cyclin D1-/-KE Rescue­cells­yields­
p­<­0.001.­(E and F)­Bar­graphs­showing­the­number­of­normal­and­abnormal­karyotypes­comparing­cyclin D1-/-Control­and­cyclin D1-/-KE Rescue 
at­72­hours­and­120­hours­post­transduction.­(G)­An­expression­profile­for­cyclin D1-/-D1 Rescue­(red­line)­and­cyclin D1-/-KE Rescue­(green­line)­
induced­genes­[16]­enriched­for­high­CIN­score­(p­<­0.0001).
Oncotarget5www.impactjournals.com/oncotarget










cyclin D1-/-D1 Rescue­vs.­cyclin D1-/-Control­MEFs­demonstrated­
increased­expression­of­genes­associated­with­a­high­CIN­
score­[30].­The­CIN­score­was­derived­by­a­computational­
approach­ to­ define­ a­ gene­ expression­ signature­ that­






Acute induction of Cyclin D1KE leads to 
expression of high CIN score genes in vivo
To­directly­determine­the­role­of­cyclin­D1-mediated­




cell­ targeted­ cyclin­D1-antisense­ or­ the­MMTV-cyclin­
D1­ transgenic­ mouse­ model­ [12,­ 22]­ (Supplementary­
Figures­ S6A­ and­ S6C).­ Mammary-targeted­ expression­
of­ cyclin­ D1­ was­ achieved­ by­ crossing­ transgenic­
mice­ carrying­ a­mammary­ gland­ targeted­ recombinant­







-CCND1KE).­ The­ resulting­ offspring­ double­
positive­ for­ the­ transgenes­ were­ designated­ rtTA/





of­ the­ cyclin­ D1­ transgene­ (Figure­ 3A).­ Microarray­














Sustained mammary gland expression of cyclin 
D1KE induces tumors independent of kinase
Next­we­employed­mammary­gland­targeted­cyclin­D1­
for­a­sustained­expression­study­(Supplementary­Figure­S6C).­
MMTV-cyclin­ D1KE­ and­MMTV-cyclin­ D1WT­ transgenic­
mice­were­monitored­twice­weekly­for­the­development­of­
mammary­tumors.­All­mice­in­the­tumor­kinetics­study­were­
nulliparous,­ thus­ eliminating­ any­potentially­ confounding­
effects­of­parity­on­tumor­development­in­the­FVB­strain.­
Mice­that­developed­palpable­tumors­were­sacrificed­within­
a­ week­ of­ tumor­ detection.­ MMTV-cyclin­ D1KE­ tumor­
incidence­ (43.8%;­n­ =­ 32­mice)­was­ similar­ to­MMTV-
cyclin­D1WT­(33.3%;­n­=­48­mice)­(p­=­0.358)­with­a­4-fold­
(p­ =­ 0.0002)­ and­ 3-fold­ (p­ =­ 0.0002)­ greater­ incidence,­
respectively,­compared­to­the­wild­type­mice­(n­=­92­mice)­





















Protein­ abundance­ from­ MMTV-cyclin­ D1KE 
transgene­in­the­mammary­tumors­was­similar­to­MMTV-
cyclin­ D1WT­ in­ the­ mammary­ gland­ (Supplementary­
Figure­S8A).­The­phosphorylation­status­of­a­CDK4/6­
target­site­in­pRB­was­substantially­reduced­in­mammary­
gland­ tumors­ of­ MMTV-cyclin­ D1KE­ compared­ to­
MMTV-cyclin­ D1WT­ tumors­ (Supplementary­ Figure­
S8B).­Gene­expression­profiles­of­the­mammary­tumors­
for­ MMTV-cyclin­ D1KE­ and­ MMTV-cyclin­ D1WT 
mice­showed­highly­significant­overlap­(p­<­1­×­10-10) 
(Supplementary­ Figure­ S9A–S9C­ and­ Dataset­ S2).­
Furthermore,­enrichment­for­CIN­gene­expression­was­
observed­with­ both­MMTV-cyclin­D1WT­ and­MMTV-
cyclin­ D1KE­ (Figure­ 3F).­ There­ were­ no­ significant­
differences­in­the­CIN­score­between­the­MMTV-cyclin­
D1WT­ and­ MMTV-cyclin­ D1KE­ tumors.­ Conversely,­
mammary­ epithelial­ cells­ from­ transgenic­ mice­ with­
Oncotarget6www.impactjournals.com/oncotarget
targeted­ cyclin­D1­ anti-sense­ induced­ by­ ponasterone­
[12]­showed­a­reciprocal­change­in­CIN­gene­expression­
(Figure­ 3F),­ highlighting­ a­ role­ for­ endogenous­





induction­ of­ CIN­ gene­ expression;­ therefore­ these­
functions­of­cyclin­D1­are­kinase-independent.
Recruitment of cyclin D1 to local chromatin is 
kinase-independent
Cyclin­ D1­ regulates­ transcription­ factor­ (TF)­




conducted­genome­wide­analysis­ comparing­ the­ cyclin­
D1WT­and­cyclin­D1KE­mutant­using­ChIP-Seq­analysis.­
















to­ both­ very­ distal­ elements­ and­ promoter­ proximal­
regulatory­elements­(Figure­4A­and­4B)­(Supplementary­
Table­S2­ and­Dataset­ S3).­The­ tag­ density­ profiles­ for­
cyclin­ D1WT­ and­ cyclin­ D1KE­ demonstrated­ a­ similar­
distribution­ of­ genomic­ association­ when­ comparing­
location­at­the­promoter,­within­a­gene­or­downstream­of­
the­transcriptional­start­site­(Figure­4B).­In­addition,­as­
in­cyclin­D1WT,­ the­ tag­density­profiles­for­cyclin­D1KE 
were­ enriched­ at­ the­ transcriptional­ start­ sites­ (Figure­
4C).­Chip-Seq­analysis­demonstrated­significant­overlap­
between­ cyclin­D1WT­ and­ cyclin­D1KE gene occupancy 
(1068­genes­in­common,­p­=­4.48­×­10-11).­Comparison­to­
a­previously­published­gene­set­from­cyclin­D1­associated­
genes­ by­ChIP-ChIP­ also­ showed­ a­ significant­ overlap­




(Figure­ 4D).­ ChIP­ analysis­ of­ selected­ target­ genes­
governing­CIN­demonstrated­ similar­ relative­occupancy­
for­ cyclin­D1WT­ and­ cyclin­D1KE­ (Figure­ 5A).­We­ then­
analyzed­a­broader­array­of­genes­governing­CIN­by­QT-
PCR,­demonstrating­similar­upregulation­of­the­transcript­
level­ by­ cyclin­D1WT­ and­ cyclin­D1KE­ (Figure­ 5B).­The­















motifs­ most­ significantly­ enriched­ in­ the­ cyclin­ D1WT 
intervals­are­shown­for­the­cyclin­D1KE­intervals­(Figure­
6B).­ In­ addition­ to­ associating­ with­ the­ TF­ motifs,­ we­
verified­that­cyclin­D1KE­regulated­the­reporter­activity­of­






studies­ had­ carefully­ characterized­ a­ mutant­ of­ cyclin­
D1­(cyclin­D1KE)­demonstrating­that­it­has­substantially­




Either­reintroduction­of­cyclin­D1KE into cyclin D1-/-­MEF,­
transient­expression­in­the­mammary­gland­in­transgenic­
mice,­or­sustained­expression­under­control­of­the­MMTV­
promoter,­was­sufficient­ for­ the­ induction­of­CIN­gene­
expression.­ The­ induction­ of­ CIN­ gene­ expression­ by­
cyclin­D1KE­was­indistinguishable­from­the­induction­of­
CIN­gene­expression­by­cyclin­D1WT.
D-type­ cyclins­ have­ been­ shown­ to­ physically­
bind­ and­ to­ either­ activate­ or­ repress­ activity­ of­
transcription­factors­[32–34].­In­reporter­gene­assays­
this­function­was­ independent­of­ the­CDK­activating­
function­ [34].­ In vivo­ using­ cyclin D1-/- mice, the 
abundance­of­cyclin­D1­was­shown­ to­be­ limiting­ in­
the­recruitment­of­transcription­factors­in­the­context­
of­ local­ chromatin­ using­ ChIP­ assays­ [19].­ ChIP­
identified­cyclin­D1­at­transcription­factor­binding­sites­
of­ endogenous­ gene­ promoters,­ associated­ with­ the­
recruitment­of­SUV39,­HP1α,­HDAC­1,­2,­and­p300­
[20,­ 31].­Cyclin­D1­determined­ the­ local­ acetylation­
and­both­di-­and­tri-­methylation­of­histones­[31].­Using­
serial­ChIP­analysis­of­non-coding­miRNA­regulatory­
regions,­ cyclin­ D1­ was­ identified­ at­ the­ regulatory­
region­ of­ miR17/20­ [35].­ The­ current­ studies­ are­
consistent­with­a­role­for­a­DNA­bound­form­of­cyclin­
D1­governing­gene­expression­independent­of­its­kinase­
function.­ Furthermore­ these­ studies­ show­ through­
quantitative­ChIP-Seq­studies­similar­binding­patterns­
for­ cyclin­ D1­ independent­ of­ its­ kinase­ function­ to­
similar­ regions­ of­ the­ genome,­ and­ similar­ levels­ of­
binding­to­individual­genes­governing­CIN.
In­the­current­studies­sustained­expression­of­either­
cyclin­ D1WT­ or­ cyclin­ D1KE­ induced­ mammary­ tumors­
in­ transgenic­mice­with­ similar­ kinetics.­ Consistent­with­
this­experimental­evidence­for­cdk­independence­of­cyclin­
D1’s­ role­ as­ a­ driver­ oncogene,­ human­ breast­ cancers­
overexpressing­cyclin­D1­do­not­ show­high­ levels­of­ the­
canonical­E2F­target­gene­cyclin­E­[4,­5]­and­exhibit­relatively­
normal­proliferation­rates­compared­to­tumors­with­genetic­
deletion­of­pRb­ [4–6,­36].­Furthermore,­ cyclin­D1­ levels­
in­tumors­do­not­correlate­with­the­marker­of­proliferating­
Figure 5: Cyclin D1WT and cyclin D1KE associate with and promotes expression of genes involved in mitosis.  





forced­ expression­ of­ either­ cyclin­ D1WT­ or­ cyclin­ D1KE 
give­very­similar­expression­patterns­of­downstream­gene­
expression,­and­ raise­ the­ intriguing­possibility­ that­cyclin­
D1­primarily­contributes­to­oncogenesis­through­regulating­
a­transcriptional­program­implicated­in­CIN.
In­ contrast,­ in­ certain­ model­ systems­ cyclin­ D1­
serves­as­a­mediator­of­mammary­tumorigenesis­induced­
by­ other­ oncogenes­ such­ as­ ErbB2,­ the­ role­ of­ cyclin­
D1­is­CDK-dependent.­For­example,­CDK4-/-­mice­and­
cyclin­D1KE­knock-in­mice­are­resistant­to­ErbB2-induced­
mammary­ tumorigenesis­ [14,­ 29,­ 38].­ Together,­ these­







studies­ may­ illustrate­ two­ distinct­ scenarios­ reflecting­
two­distinct­clinical-pathological­settings.­Cyclin­D1­is­






of­ cyclin­ D1­ but­ also­ by­ CDK4/6­ inhibition.­ CDK4/6­
inhibitors­(Palbociclib,­LEE011,­LY2835219),­currently­
in­ various­ stages­ of­ phase­ clinical­ trial,­ are­ showing­
























Generation of transgenic mice
Two­ 8­ amino­ acid­ FLAG­ tagged­ constructs­ were­








tagged­ construct,­ plus­ SV40­ intron­ and­ polyadenylation­
signals,­ was­microinjected­ into­ fertilized­ FVB/N­mouse­
oocytes­ and­ implanted­ into­pseudopregnant­FVB­ fosters­
using­standard­methods.­Pups­were­examined­for­successful­
insertion­of­ the­ respective­ transgenes­using­ tail­genomic­































Retrovirus production and infection
Retroviral­ production­ and­ infection­ of­ cyclin 
D1−/−­MEFs­cells­were­described­in­detail­previously­[46].
ChIP-Seq analysis and transcription factor 
enrichment
Detailed­methods­of­chromatin­preparation,­labeling­






























the­ default­ parameters­ to­ find­ all­ vertabrate­ transcription­
factor­binding­sites.­We­then­assessed­the­overlap­between­
these­ transcription­ factor­ binding­ sites­ and­ the­ cyclin­
D1KE­ peak­ intervals.­We­used­ a­ permutation­ test­ initially­
proposed­by­Tuteja­et­ al,­ [50].­ In­brief,­ this­ test­ involves­








To­ determining­ overlap­ between­ cyclin­ D1WT­ and­
cyclin­D1KE­cyclin­D1­binding-sites­we­used­both­a­gene-
based­method­and­an­interval­based­method.­For­the­interval­
based­ method­ we­ used­ the­ same­ permutation­ method­ as­
described­for­the­transcription­factor­enrichment­to­determine­
the­overlap­between­ the­cyclin­D1WT­and­ the­cyclin­D1KE 
mutant­ binding­ sites.­ We­ used­ the­ intervals­ published­
previously­for­the­cyclin­D1WT­intervals­[22].­Significance­













the­ discrete­ nature­ of­ the­ distribution­ we­ truncated­ to­
the­maximum­ difference,­ 855­ counts­ in­ this­ case,­ and­
re-normalized­the­distribution.­We­then­calculated­the­p-
value­for­each­transcription­factor­as­1-cdf­(delta).
Chromatin immuno-precipitation assay (ChIP)



































chromosomal­ number­ and­ structural­ alterations­ of­
chromosomes,­including­simple­balanced­translocations,­























Western blotting and luciferase assays
The­ following­ antibodies­ were­ used­ for­Western­
blotting:­ Guanine­ Nucleotide­ Dissociation­ Inhibitor­
(GDI)­[40],­Cyclin­D1­(NeoMarkers,­MS-210-P),­FLAG­
M2­antibody­(Sigma­Aldrich,­#F1804),­β-Tubulin­(Sigma­





Immunofluorescence and confocal analysis
Immunofluorescence­was­performed­as­described­
previously­[22].­Cyclin D1-/-Control, cyclin D1-/-D1 Rescue­and­
cyclin D1-/-KE Rescue­subcellular­localization­was­determined­
using­ the­ M2­ anti-FLAG­ antibody­ (Sigma-Aldrich,­
#F1804).­ The­ whole­ cell­ fluorescence­ intensity­ per­
pixel2­was­normalized­to­WT­signal­intensity.­A­one-way­









MACs­ algorithm­ was­ employed­ to­ determine­
number­ of­ ChIP-Seq­ peaks­ (FDR­ =­ 4.35%).­Analysis­
of­ transcription­ factor­ enrichment­ within­ the­ interval­
sequences­produced­by­the­ChIP-Seq­data­was­computed­
using­ a­ permutation­ test.­ Enrichment­ for­ high­ CIN­
scoring­ genes­ [30]­ between­ two­ sets­ compared­ using­
Wilcoxon­matched­paired­test.­Kaplan–Meier­plots­were­
compared­ by­ log-rank­ test.­ For­ comparison­ between­
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